[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA200711240B - Kinin antagonists for treating bladder dysfunction - Google Patents

Kinin antagonists for treating bladder dysfunction

Info

Publication number
ZA200711240B
ZA200711240B ZA200711240A ZA200711240A ZA200711240B ZA 200711240 B ZA200711240 B ZA 200711240B ZA 200711240 A ZA200711240 A ZA 200711240A ZA 200711240 A ZA200711240 A ZA 200711240A ZA 200711240 B ZA200711240 B ZA 200711240B
Authority
ZA
South Africa
Prior art keywords
bladder dysfunction
treating bladder
kinin antagonists
kinin
antagonists
Prior art date
Application number
ZA200711240A
Other languages
English (en)
Inventor
Gibson Christoph
Hummel Gerd
Knolle Jochen
Reineke Ulrich
Tradler Thomas
Original Assignee
Jerini Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jerini Ag filed Critical Jerini Ag
Publication of ZA200711240B publication Critical patent/ZA200711240B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA200711240A 2005-07-05 2007-12-21 Kinin antagonists for treating bladder dysfunction ZA200711240B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05014581A EP1741444A1 (en) 2005-07-05 2005-07-05 Kinin antagonists for treating bladder dysfunction

Publications (1)

Publication Number Publication Date
ZA200711240B true ZA200711240B (en) 2008-08-27

Family

ID=34937780

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200711240A ZA200711240B (en) 2005-07-05 2007-12-21 Kinin antagonists for treating bladder dysfunction

Country Status (17)

Country Link
US (1) US20080221039A1 (ko)
EP (2) EP1741444A1 (ko)
JP (1) JP2009500362A (ko)
KR (1) KR20080025120A (ko)
CN (1) CN101212985A (ko)
AR (1) AR054820A1 (ko)
AT (1) ATE521365T1 (ko)
AU (1) AU2006265266A1 (ko)
BR (1) BRPI0613724A2 (ko)
CA (1) CA2613627A1 (ko)
IL (1) IL188316A0 (ko)
RU (1) RU2008104134A (ko)
SG (1) SG163564A1 (ko)
TW (1) TW200800249A (ko)
UA (1) UA96573C2 (ko)
WO (1) WO2007003411A2 (ko)
ZA (1) ZA200711240B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
DE102005013967A1 (de) * 2004-11-05 2006-10-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
FR2919803B1 (fr) * 2007-08-07 2011-07-22 Sanofi Aventis Utilisation d'un antagoniste non peptidique du recepteur b1 pour la preparation de medicaments utiles pour le traitement de l'obesite et des pathologies liees a l'obesite ou au diabete
ATE518849T1 (de) * 2008-02-06 2011-08-15 Boehringer Ingelheim Int Arylsulfonamide wirksam als schmerzmittel
IT1391236B1 (it) 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
US20130323288A1 (en) 2010-07-08 2013-12-05 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
US9415048B2 (en) 2010-07-08 2016-08-16 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
SG11201500410XA (en) * 2012-01-04 2015-04-29 Wellesley Pharmaceuticals Llc Delayed-release formulation for reducing the frequency of urination and method of use thereof
AU2013293488B2 (en) * 2012-07-27 2018-05-17 David A. Dill Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US10792326B2 (en) 2013-06-28 2020-10-06 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
EP3027199B1 (en) 2013-08-01 2019-06-26 Dignify Therapeutics, LLC Compositions and methods for inducing urinary voiding and defecation
CN103588861B (zh) * 2013-10-25 2015-11-04 中国药科大学 新德里金属β-内酰胺酶的抑制肽及其应用
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
TWI768156B (zh) 2017-11-24 2022-06-21 荷蘭商帕法瑞斯荷蘭有限公司 新穎緩激肽ｂ２受體拮抗劑及其用途
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9505491D0 (en) * 1995-03-18 1995-05-03 Merck Sharp & Dohme Therapeutic agents
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
SK862003A3 (en) * 2000-06-28 2003-06-03 Teva Pharma Carvedilol
FR2822827B1 (fr) * 2001-03-28 2003-05-16 Sanofi Synthelabo Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
AU2002323151A1 (en) * 2001-08-13 2003-03-03 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
CA2473778A1 (en) * 2002-02-08 2003-08-14 Merck & Co., Inc. N-biphenylmethyl aminocycloalkanecarboxamide derivatives
US20040044041A1 (en) * 2002-08-06 2004-03-04 Kuduk Scott D. 2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives
WO2004066990A2 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Methods of treating lower urinary tract disorders using sodium channel modulators
EP1590458B1 (en) * 2003-02-06 2012-10-31 Queen's University Of Belfast Bradykinin b2 receptor antagonist peptide from amphibian skin
WO2004084879A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators

Also Published As

Publication number Publication date
WO2007003411A3 (en) 2007-05-18
JP2009500362A (ja) 2009-01-08
AU2006265266A1 (en) 2007-01-11
IL188316A0 (en) 2008-04-13
US20080221039A1 (en) 2008-09-11
RU2008104134A (ru) 2009-08-10
CA2613627A1 (en) 2007-01-11
EP1741444A1 (en) 2007-01-10
ATE521365T1 (de) 2011-09-15
SG163564A1 (en) 2010-08-30
UA96573C2 (ru) 2011-11-25
AR054820A1 (es) 2007-07-18
EP1901775A2 (en) 2008-03-26
CN101212985A (zh) 2008-07-02
BRPI0613724A2 (pt) 2011-02-08
KR20080025120A (ko) 2008-03-19
TW200800249A (en) 2008-01-01
EP1901775B1 (en) 2011-08-24
WO2007003411A2 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
IL188316A0 (en) Kinin antagonists for treating bladder dysfunction
IL222922A0 (en) Neuropilin antagonists
GB0604483D0 (en) Neuromodulation device for pelvic dysfunction
IL239403A0 (en) Kinase antagonists
GB2432379B (en) Reverse out valve for well treatment operations
EP1996710A4 (en) ANTI-DYSFUNCTION RECTAL PREPARATION OF RIFAXIMINE
IL187657A0 (en) Substituted arylpyrazoles for use against parasitites
EP1906805A4 (en) sHOWER DEVICE
TWI318966B (en) Device for treating water
EP1940397A4 (en) METHOD FOR TREATING HYPERTONIA
SG156674A1 (en) Asphaltene inhibition
PL2065206T3 (pl) Urządzenie do uszlachetniania detali
EP1874302A4 (en) ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
EP1968581A4 (en) TETRACYCLIC KINASE INHIBITORS
IL204928A0 (en) Cgrp antagonists
EP1877925A4 (en) METHOD FOR ACCELERATING THE CONNECTION TERMINATION TIME
GB201000798D0 (en) Poly-TLR antagonists
HK1097170A1 (en) Shower apparatus
HU0400305D0 (en) Set for spine-fixture
GB0510238D0 (en) Shower apparatus
GB0404567D0 (en) Methods for treating bladder dysfunction and related compounds and compositions
HK1172547A1 (en) Activin-actrii antagonists for use in treating anemia -actrii
GB0403408D0 (en) Valve apparatus
GB0518945D0 (en) Rapid-opening valve for well bores
GB0516617D0 (en) EP2 Receptor antagonists